(Q43067439)

English

Results of a randomized and controlled clinical trial evaluating the efficacy and safety of combination therapy with Endostar and S-1 combined with oxaliplatin in advanced gastric cancer

scientific article published on 25 July 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Results of a randomized and controlled clinical trial evaluating the efficacy and safety of combination therapy with Endostar and S-1 combined with oxaliplatin in advanced gastric cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

1 reference

based on heuristic

inferred from title

author name string

Rong Xu

1

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Nan Ma

2

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Fang Wang

3

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Lei Ma

4

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Rui Chen

5

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Ru Chen

6

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Mijiti Kebinu

7

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Lili Ma

8

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Zhongcheng Han

9

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Ayixiamu

10

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Mahemiti Mayier

11

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Pengcheng Su

12

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Yiming Naman

13

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Haliyazimu Jieensi

14

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Haixuan Yang

15

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Abulizi Adili

16

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Saiding Aili

17

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Jiang Liu

18

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

language of work or name

0 references

publication date

25 July 2013

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

OncoTargets and Therapy

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

6

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

925-929

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

copyright license

Creative Commons Attribution-NonCommercial 3.0 Unported

1 July 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Endostar combined with chemotherapy for treatment of metastatic colorectal and gastric cancer: a pilot study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3728266

25 May 2018

A randomized phase II trial of S-1-oxaliplatin versus capecitabine-oxaliplatin in advanced gastric cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3728266

25 May 2018

Therapeutic effects of combined oxaliplatin and S-1 in older patients with advanced gastric cardiac adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3728266

25 May 2018

Phase II study of cisplatin/etoposide and endostar for extensive-stage small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3728266

25 May 2018

Results of randomized, multicenter, double-blind phase III trial of rh-endostatin (YH-16) in treatment of advanced non-small cell lung cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3728266

25 May 2018

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3728266

25 May 2018

A phase II study of S-1 and oxaliplatin (SOx) combination chemotherapy as a first-line therapy for patients with advanced gastric cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3728266

25 May 2018

Phase II study of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer (G-SOX study).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3728266

25 May 2018

Process in the mechanisms of endostatin combined with radiotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3728266

25 May 2018

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3728266

25 May 2018

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3728266

25 May 2018

Epidemiology of gastric cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3728266

25 May 2018

Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3728266

25 May 2018

Endostatin (EntreMed).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3728266

25 May 2018

Role of angiogenesis in tumor growth and metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3728266

25 May 2018

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3728266

25 May 2018

Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3728266

25 May 2018

Initial or delayed chemotherapy with best supportive care in advanced gastric cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3728266

25 May 2018

Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3728266

25 May 2018

Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3728266

15 August 2018

Endostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR/Flk-1 of endothelial cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3728266

15 August 2018

Chemotherapy of gastric cancer--a review of clinical trials in Japan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3728266

15 August 2018

Early efficacy of Endostar combined with chemoradiotherapy for advanced cervical cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/23926435

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2147/OTT.S46487

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43067439&oldid=1979221113"